Cancer exosomes for early pancreatic cancer diagnosis and role in metastasis

Murray Korc, Samantha Deitz McElyea

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Pancreatic ductal adenocarcinoma (PDAC) is a treatment-recalcitrant and highly metastatic cancer. Recent studies have demonstrated that PDAC is associated with an increased release of small vesicles called exosomes that are ~40 to 130 nanometers in diameter. These exosomes may derive from pancreatic cancer cells, cancer-associated fibroblasts, and infiltrating immune and inflammatory cells. They carry a cargo rich in proteins, lipids, DNA, and microRNAs. Exosomes can modulate the tumor microenvironment, promote pancreatic cancer cell proliferation, invasion, and metastasis, and prime the pre-metastatic niche to facilitate formation of distant metastatic lesions. Components of the exosomal cargo may also serve as diagnostic biomarkers and guide the design of precision medicine strategies. Finally, exosomes have been proposed to act as biological nanoparticles that can be loaded with drugs for therapeutic use.

Original languageEnglish (US)
Title of host publicationPancreatic Cancer
PublisherSpringer New York
Pages1361-1377
Number of pages17
ISBN (Electronic)9781493971930
ISBN (Print)9781493971916
DOIs
StatePublished - Apr 11 2018

Fingerprint

Exosomes
Pancreatic Neoplasms
Early Detection of Cancer
Neoplasm Metastasis
Neoplasms
Adenocarcinoma
Precision Medicine
Tumor Microenvironment
Therapeutic Uses
MicroRNAs
Nanoparticles
Biomarkers
Cell Proliferation
Lipids
DNA
Pharmaceutical Preparations
Proteins

Keywords

  • Early diagnosis
  • Exosomes
  • Metastasis
  • MicroRNAs

ASJC Scopus subject areas

  • Medicine (miscellaneous)

Cite this

Korc, M., & McElyea, S. D. (2018). Cancer exosomes for early pancreatic cancer diagnosis and role in metastasis. In Pancreatic Cancer (pp. 1361-1377). Springer New York. https://doi.org/10.1007/978-1-4939-7193-0_67

Cancer exosomes for early pancreatic cancer diagnosis and role in metastasis. / Korc, Murray; McElyea, Samantha Deitz.

Pancreatic Cancer. Springer New York, 2018. p. 1361-1377.

Research output: Chapter in Book/Report/Conference proceedingChapter

Korc, M & McElyea, SD 2018, Cancer exosomes for early pancreatic cancer diagnosis and role in metastasis. in Pancreatic Cancer. Springer New York, pp. 1361-1377. https://doi.org/10.1007/978-1-4939-7193-0_67
Korc M, McElyea SD. Cancer exosomes for early pancreatic cancer diagnosis and role in metastasis. In Pancreatic Cancer. Springer New York. 2018. p. 1361-1377 https://doi.org/10.1007/978-1-4939-7193-0_67
Korc, Murray ; McElyea, Samantha Deitz. / Cancer exosomes for early pancreatic cancer diagnosis and role in metastasis. Pancreatic Cancer. Springer New York, 2018. pp. 1361-1377
@inbook{d95aa8dbc0fc412d93471fb8b64ea9d6,
title = "Cancer exosomes for early pancreatic cancer diagnosis and role in metastasis",
abstract = "Pancreatic ductal adenocarcinoma (PDAC) is a treatment-recalcitrant and highly metastatic cancer. Recent studies have demonstrated that PDAC is associated with an increased release of small vesicles called exosomes that are ~40 to 130 nanometers in diameter. These exosomes may derive from pancreatic cancer cells, cancer-associated fibroblasts, and infiltrating immune and inflammatory cells. They carry a cargo rich in proteins, lipids, DNA, and microRNAs. Exosomes can modulate the tumor microenvironment, promote pancreatic cancer cell proliferation, invasion, and metastasis, and prime the pre-metastatic niche to facilitate formation of distant metastatic lesions. Components of the exosomal cargo may also serve as diagnostic biomarkers and guide the design of precision medicine strategies. Finally, exosomes have been proposed to act as biological nanoparticles that can be loaded with drugs for therapeutic use.",
keywords = "Early diagnosis, Exosomes, Metastasis, MicroRNAs",
author = "Murray Korc and McElyea, {Samantha Deitz}",
year = "2018",
month = "4",
day = "11",
doi = "10.1007/978-1-4939-7193-0_67",
language = "English (US)",
isbn = "9781493971916",
pages = "1361--1377",
booktitle = "Pancreatic Cancer",
publisher = "Springer New York",

}

TY - CHAP

T1 - Cancer exosomes for early pancreatic cancer diagnosis and role in metastasis

AU - Korc, Murray

AU - McElyea, Samantha Deitz

PY - 2018/4/11

Y1 - 2018/4/11

N2 - Pancreatic ductal adenocarcinoma (PDAC) is a treatment-recalcitrant and highly metastatic cancer. Recent studies have demonstrated that PDAC is associated with an increased release of small vesicles called exosomes that are ~40 to 130 nanometers in diameter. These exosomes may derive from pancreatic cancer cells, cancer-associated fibroblasts, and infiltrating immune and inflammatory cells. They carry a cargo rich in proteins, lipids, DNA, and microRNAs. Exosomes can modulate the tumor microenvironment, promote pancreatic cancer cell proliferation, invasion, and metastasis, and prime the pre-metastatic niche to facilitate formation of distant metastatic lesions. Components of the exosomal cargo may also serve as diagnostic biomarkers and guide the design of precision medicine strategies. Finally, exosomes have been proposed to act as biological nanoparticles that can be loaded with drugs for therapeutic use.

AB - Pancreatic ductal adenocarcinoma (PDAC) is a treatment-recalcitrant and highly metastatic cancer. Recent studies have demonstrated that PDAC is associated with an increased release of small vesicles called exosomes that are ~40 to 130 nanometers in diameter. These exosomes may derive from pancreatic cancer cells, cancer-associated fibroblasts, and infiltrating immune and inflammatory cells. They carry a cargo rich in proteins, lipids, DNA, and microRNAs. Exosomes can modulate the tumor microenvironment, promote pancreatic cancer cell proliferation, invasion, and metastasis, and prime the pre-metastatic niche to facilitate formation of distant metastatic lesions. Components of the exosomal cargo may also serve as diagnostic biomarkers and guide the design of precision medicine strategies. Finally, exosomes have been proposed to act as biological nanoparticles that can be loaded with drugs for therapeutic use.

KW - Early diagnosis

KW - Exosomes

KW - Metastasis

KW - MicroRNAs

UR - http://www.scopus.com/inward/record.url?scp=85054045874&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85054045874&partnerID=8YFLogxK

U2 - 10.1007/978-1-4939-7193-0_67

DO - 10.1007/978-1-4939-7193-0_67

M3 - Chapter

AN - SCOPUS:85054045874

SN - 9781493971916

SP - 1361

EP - 1377

BT - Pancreatic Cancer

PB - Springer New York

ER -